ABIOMED, Inc. (ABMD) Q1 2023 Earnings Call Transcript
ABIOMED, Inc. (NASDAQ: ABMD) Q1 2023 earnings call dated Aug. 04, 2022 Corporate Participants: Nicole Nath — Manager of Investor Relations Michael R. Minogue — Chairman, Chief Executive Officer…
11 articles, transcripts, and reports
ABIOMED, Inc. (NASDAQ: ABMD) Q1 2023 earnings call dated Aug. 04, 2022 Corporate Participants: Nicole Nath — Manager of Investor Relations Michael R. Minogue — Chairman, Chief Executive Officer…
Medical devices like ventilators and personal protective equipment are in high demand during the pandemic and their shortage often adds to the burden of the…
Abiomed, Inc. (NASDAQ: ABMD) Q1 2022 earnings call dated Aug. 05, 2021 Corporate Participants: Todd A. Trapp — Vice President and Chief Financial Officer Michael R. Minogue — Chairman,…
Abiomed, Inc. (NASDAQ: ABMD) Q4 2021 earnings call dated Apr. 29, 2021 Corporate Participants: Todd A. Trapp — Vice President and Chief Financial Officer Michael R. Minogue — Chairman,…
Abiomed, Inc. (NASDAQ: ABMD) Q3 2021 earnings call dated Jan. 28, 2021 Corporate Participants: Todd A. Trapp — Vice President and Chief Financial Officer Michael R. Minogue — Chairman,…
Abiomed Inc (ABMD) Q4 2020 earnings call dated Apr. 30, 2020 Corporate Participants: Todd A.Trapp — Vice President and Chief Financial Officer Michael R. Minogue — Chairman of the…
Medical device maker Abiomed, Inc. (NASDAQ: ABMD) reported a decline in fourth quarter earnings even as revenues remained flat. The company withheld its full-year guidance,…
Abiomed Inc (NASDAQ: ABMD) Q3 2020 Earnings Conference Call February 06, 2020 Corporate Participants: Todd A. Trapp — Vice President and Chief Financial Officer Michael R. Minogue — Chairman…
Shares of Abiomed Inc. (NASDAQ: ABMD) were down 4% in afternoon trade on Wednesday. The stock has dropped 22% over the past three months and…
— Medical device maker Abiomed, Inc. (NASDAQ: ABMD) reported net income of $69.2 million or $1.51 per share for the third quarter of 2020, vs.…